Company intelligence / Profile preview

MedicaMetrix

Lowell, Massachusetts, United States

Ownership: Private
Employees: ~8
Development stage: Other

Overview

The ProstaMetrix Platform uses fiber optic sensors and proprietary technology to measure prostate volume and calculate prostate density during digital rectal exams. The device provides real-time results in-office, aims to distinguish aggressive from indolent prostate cancers, and reduces unnecessary biopsies and imaging procedures.

Therapeutic areas: NephrologyOncologyMen's Health
Modalities: Device
Industry: Physiological Monitoring

Partnerships

Emerson Hospital (partnership announced December 2021 for establishing urology centers globally)16 UK and Dutch institutions engaged for product implementation

Beyond the preview

Go deeper on MedicaMetrix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MedicaMetrix.

Explore the full profile